(Q34375146)

1 August 2017

title

Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases (English)

1 reference

1 August 2017

D Larrey

1

1 reference

1 August 2017

T Vial

2

1 reference

1 August 2017

A Micaleff

3

1 reference

1 August 2017

G Babany

4

1 reference

1 August 2017

M Morichau-Beauchant

5

1 reference

1 August 2017

H Michel

6

1 reference

1 August 2017

J P Benhamou

7

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 March 1992

1 reference

1 August 2017

1 reference

1 August 2017

volume

33

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

368-371

1 reference

Ticarcillin-clavulanic acid therapy in severe infections.

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373830

Amoxicillin-clavulanic acid versus cefaclor in the treatment of urinary tract infections and their effects on the urogenital and rectal flora

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373830

Amoxicillin-clavulanate potassium-associated cholestasis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373830

Cholestatic hepatitis due to an amoxycillin/clavulanic acid preparation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373830

Cholestatic hepatitis due to antibacterial combination of amoxicillin and clavulanic acid (augmentin)

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373830

Amoxycillin/clavulanic acid (Augmentin)-induced intrahepatic cholestasis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373830

Pharmacovigilance. The French system

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373830

Amoxycillin/clavulanic acid induced cholestasis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373830

Cholestatic hepatitis induced by the amoxicillin-clavulanic acid combination. A case and review of the literature

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373830

Criteria of drug-induced liver disorders. Report of an international consensus meeting

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373830

Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373830

Cholestatic hepatitis after therapy with amoxicillin/clavulanate potassium

6 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1568657

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Hepatic cholestasis probably due to the combination of amoxicillin and clavulanic acid

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1568657

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/GUT.33.3.368

1 reference

1 August 2017

1 reference

1 August 2017

1 reference